Robert Pukose

All parliamentary appearances

Entries 201 to 210 of 2869.

• 22 Sep 2021 in National Assembly: It will also strengthen and harmonise regulatory systems in Kenya to improve predictability and efficiency of marketing approvals. This is so that innovative new health technologies can be delivered and used sooner, ultimately improving health outcomes of patients in need. This also avoids duplication of regulatory review, accelerates scientific risks benefit adjusted reviews, facilitates recognition and accelerates access. Towards this end, the scope of Food and Drug Safety legislation is generally defined by the category of the products. view
• 22 Sep 2021 in National Assembly: Thank you, Hon. Deputy Speaker. The purpose of the KFDA Bill is to safeguard the health and safety of consumers with regard to broad categories of products which they routinely consume. Those are food and medicines. The measures outlined in the Bill seek to ensure that food is safe and of adequate nutrition and the medicines and other products used in health care are safe, efficacious and of acceptable quality. The Bill is expected to address chronic weaknesses in the existing regulatory and control systems. In as far as drugs are concerned, Kenya has a national regulatory authority for assuring ... view
• 22 Sep 2021 in National Assembly: Thank you, Hon. Deputy Speaker. The purpose of the KFDA Bill is to safeguard the health and safety of consumers with regard to broad categories of products which they routinely consume. Those are food and medicines. The measures outlined in the Bill seek to ensure that food is safe and of adequate nutrition and the medicines and other products used in health care are safe, efficacious and of acceptable quality. The Bill is expected to address chronic weaknesses in the existing regulatory and control systems. In as far as drugs are concerned, Kenya has a national regulatory authority for assuring ... view
• 22 Sep 2021 in National Assembly: The regulatory bodies of those professions had made attempts to fill the historical gap through expanding their mandates to include the regulation of various categories of medical devices. The ensuing conflict resulted in several instances of litigation aimed at retaining control over the market for medical devices. view
• 22 Sep 2021 in National Assembly: The regulatory bodies of those professions had made attempts to fill the historical gap through expanding their mandates to include the regulation of various categories of medical devices. The ensuing conflict resulted in several instances of litigation aimed at retaining control over the market for medical devices. view
• 22 Sep 2021 in National Assembly: Hon. Deputy Speaker, with specific categories in as far as how the KFDA contribute to the Big Four Agenda… I have talked about the universal healthcare which is important. I have talked about economies in terms of business, medicines, medical devices and biological products. It might be too technical when we talk about biological products, but I know some Members will understand. In medicine, we talk about therapeutic, meaning products that can treat. They have to be safe. They have to perform the intended function and are produced using appropriate standards and the benefits to human health associated with their ... view
• 22 Sep 2021 in National Assembly: Hon. Deputy Speaker, with specific categories in as far as how the KFDA contribute to the Big Four Agenda… I have talked about the universal healthcare which is important. I have talked about economies in terms of business, medicines, medical devices and biological products. It might be too technical when we talk about biological products, but I know some Members will understand. In medicine, we talk about therapeutic, meaning products that can treat. They have to be safe. They have to perform the intended function and are produced using appropriate standards and the benefits to human health associated with their ... view
• 22 Sep 2021 in National Assembly: technologies, control of clinical trials, conduct advertising and promotion, post marketing surveillance for quality, safety and disposal of health products and health technologies and regulate contractors for medical devices and physical security for products, including radioactive materials and biological products. The Health Act further provides that the legislation contemplated under Section 62 shall provide for the granting of marketing approval only by a technically competent body after appropriate assessment has established that such a product generally meets the recognised standards and approval made subject to conditions notably with respect to the conduct and content on promotion and advertising. Despite the ... view
• 22 Sep 2021 in National Assembly: technologies, control of clinical trials, conduct advertising and promotion, post marketing surveillance for quality, safety and disposal of health products and health technologies and regulate contractors for medical devices and physical security for products, including radioactive materials and biological products. The Health Act further provides that the legislation contemplated under Section 62 shall provide for the granting of marketing approval only by a technically competent body after appropriate assessment has established that such a product generally meets the recognised standards and approval made subject to conditions notably with respect to the conduct and content on promotion and advertising. Despite the ... view
• 22 Sep 2021 in National Assembly: For prevention and control of poisoning, there will be a national poisons information service and provisions for the designation of poisons centres. You will find that people have taken in some poisons in whatever corner it is. How do you access information on what you need to do in as far as poisons are concerned? These are emergencies. People who have taken “rat rat” and are in the corner of Kabuchai, can call the national poisons centre and be advised on what to do. For appeals from decisions made under the KFDA Act, we will have the Kenya Food and ... view